Skip to content
PeptideTech
Cart

Tesamorelin vs Tirzepatide: research-use price per mg, identity and FDA status (2026)

Tesamorelin and Tirzepatide are different research compounds, not substitutes for each other: Tesamorelin is a 44-amino-acid peptide (C221H366N72O67S); Tirzepatide is a single compound (C225H348N48O68). Lowest current research-use listings: Tesamorelin 10mg from $69.99 ($7.00/mg) at Amino Club; Tirzepatide 30mg from $59.99 ($2.00/mg) at Amino Club. Tesamorelin shares its active ingredient with an FDA-approved prescription medicine; Tirzepatide shares its active ingredient with an FDA-approved prescription medicine.

Research use only. These are research-use-only listings sold for laboratory research, not prescription medicines and not for human use. PeptideTech does not compare effects or provide dosing information.

PTBy PeptideTech EditorsSource timestamps on offersHow we verify →
All products listed are for research purposes only. Not for human consumption.

Tesamorelin vs Tirzepatide: current prices and packages

Compared propertyTesamorelinTirzepatide
CategoryGrowth hormoneGLP-1
Compared package10mg · Vial30mg · Vial
Lowest current price$69.99 at Amino Club, checked Oct 14, 2026$59.99 at Amino Club, checked Oct 14, 2026
Price per labelled mg$7.00/mg$2.00/mg
Package sizes2mg, 5mg, 10mg, 20mg, 50mg10mg, 15mg, 20mg, 30mg, 40mg, 60mg, 100mg
Vendors with current prices5 (6 tracked)3 (4 tracked)
Form at this packageVialVial
StockIn stockIn stock

Prices exclude shipping. The price per labelled mg is always given per mg, so different package sizes compare directly; it is shown only for single-compound vials and powders with a labelled mass. Blends, capsules, liquids and IU-labelled packages are compared by package total.

Identity, regulatory status and registered research

Compared propertyTesamorelinTirzepatide
Molecular formulaC221H366N72O67SC225H348N48O68
Molecular weight5136 g/mol4813 g/mol
SequenceYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL (44 residues)—
CAS Registry Number218949-48-5—
Registered clinical trials20 (3 active) · Phase 4: 2, Phase 3: 2, Phase 2: 938 (38 active) · Phase 4: 9, Phase 3: 6, Phase 2: 14
Human intervention studies77
US regulatory statusFDA-approved prescription medicine with this active ingredient: Egrifta (BLA 022505; checked October 7, 2026)MarketedEGRIFTA · BLA 022505 · 2010Research listings are not these medicines.FDA-approved prescription medicine with this active ingredient: Mounjaro and Zepbound (NDA 215866 and NDA 217806; checked October 7, 2026)MarketedMOUNJARO · NDA 215866 · 2022ZEPBOUND · NDA 217806 · 2023Research listings are not these medicines.

Identity data: PubChem, FDA GSRS and EPA records; registry counts: ClinicalTrials.gov; status: Drugs@FDA. A matching name does not verify the contents of a supplier's lot.

Key human studies

Studies are listed as records, newest first; they are not evidence that a research product is safe or effective.

Research-use listings for each compound

Research-use-only listings sold for laboratory research, not prescription medicines and not for human use.

Tesamorelin

Tesamorelin is a catalogue entry whose compound-specific reference review has not yet been completed.

$69.99 · 10mg · $7.00/mg · Amino Club

View at Amino Club, Tesamorelin 10mg, opens in a new tabPeptideTech does not sell or fulfill products. Some outgoing links can earn a commission, which does not determine price order. How we rankTesamorelin prices →Price history →

Tirzepatide

Tirzepatide acts at GIP and GLP-1 receptors and is the active substance in the EU-authorized prescription medicine Mounjaro. Its medicinal-product assessment is separate from a supplier’s research catalogue listing.

$59.99 · 30mg · $2.00/mg · Amino Club

View at Amino Club, Tirzepatide 30mg, opens in a new tabPeptideTech does not sell or fulfill products. Some outgoing links can earn a commission, which does not determine price order. How we rankTirzepatide prices →Price history →

Questions

No. The listings compared here are research-use-only products sold for laboratory research, not medicines for human use, and PeptideTech does not compare effects or provide dosing information. US regulatory status: Tesamorelin: FDA-approved prescription medicine with this active ingredient: Egrifta (BLA 022505; checked October 7, 2026); Tirzepatide: FDA-approved prescription medicine with this active ingredient: Mounjaro and Zepbound (NDA 215866 and NDA 217806; checked October 7, 2026).

Compare another pair

Opens a side-by-side page with current prices, the price per labelled mg where a single-compound mass is listed, sizes, identity data and regulatory status. The products are not interchangeable.

How we verify prices

Automated price sources are scheduled daily; other sources are checked manually. Check the offer's last successful source timestamp. A code is shown when it is attached to an offer or affiliate link. The displayed price includes a discount only when that code is cart-verified and the discounted price is explicitly recorded; otherwise it is the vendor's listed price. Prices exclude shipping. Stock status is captured at the same time. Rankings are by displayed price only. PeptideTech earns a commission when you buy through a link; it never changes the order.

Full method →